Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.

Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials.

HIV in 2025: What’s New, What’s Next? 

HIV in 2025: What’s New, What’s Next? 
Session moderated by Bob Wachter

Advances in HIV treatment have rapidly accelerated, with promising new trials and therapies emerging every year. In this Grand Rounds, one of our HIV experts, Annie Luetkemeyer, MD, will review current and emerging treatment and prevention tools and explore how these innovations are reshaping the landscape of HIV management. She will also discuss recent advances in the prevention of other sexually transmitted infections, another important strategy in HIV prevention.

Speaker:

Annie Luetkemeyer, MD, is a professor of medicine in the Division of HIV, Infectious Diseases, and Global Medicine at ZSFG.  She is the principal investigator for the UCSF AIDS Clinical Trials Group (ACTG) clinical research site and directs the San Francisco Infectious Diseases Research Center (SF IDRC). Her research focuses on interventions to treat and prevent viral and sexually transmitted infections, with an emphasis on underserved populations and people living with HIV.

How to Attend

In Person:
S-214 (Medical Sciences Building) 
Lunch will be provided

On Zoom:
Join from a PC, Mac, iPad, iPhone or Android device:
https://ucsf.zoom.us/j/97645766587?pwd=OpxbkAwpMENJgLN8xpPHofjwzHD8JH.1
Webinar ID: 976 4576 6587
Passcode: 364678

By Phone (for higher quality, dial a number based on your current location):
US: +1 669 900 6833 or +1 213 338 8477 or +1 669 219 2599
International numbers available: https://ucsf.zoom.us/u/abt1xcyvsc

The session will be recorded for later play. See all past recordings.

The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.

The food and drug administration is now preparing to establish tighter performance requirements for blood glucose monitors.

Psychological stress preceding idiopathic ventricular fibrillation.

Colorectal metastases confined to the liver: a unique opportunity?

The Unmet Educational Needs of Patients with Interstitial Lung Disease. Setting the Stage for Tailored Pulmonary Rehabilitation.

Functional analysis of natural killer cell receptors in the RNK-16 rat leukemic cell line.

Impact of multiple substance use on circulating ST2, a biomarker of adverse cardiac remodelling, in women.

Trends in Timing of Preemptive Kidney Transplantation and Association with Allograft and Survival Outcomes in Children.

Bay Area Older Adult Community Resource of the Week – SilverRide

This week's "Bay Area Older Adult Community Resource of the week" to be featured is SilverRide.

SilverRide is a flexible, tech-driven, fully licensed TNC operator platform for paratransit, healthcare providers, and senior transportation. Their focus is on the rider experience which makes them the ideal choice for agencies, senior-focused organizations, and medical providers. For more information or to make a reservation inquiry, you can reach out to them at [email protected] or call 1-800-618-1246.

Find other Geriatrics Community Resources here>>

Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.

Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force.

HIT: a versatile proteomics platform for multianalyte phenotyping of cytokines, intracellular proteins and surface molecules.